Skip to main content
Top
Published in: Clinical and Experimental Nephrology 2/2013

01-04-2013 | Original Article

A nationwide study of mass urine screening tests on Korean school children and implications for chronic kidney disease management

Authors: Byoung-Soo Cho, Won-Ho Hahn, Hae Il Cheong, Inseok Lim, Cheol Woo Ko, Su-Young Kim, Dae-Yeol Lee, Tae-Sun Ha, Jin-Soon Suh

Published in: Clinical and Experimental Nephrology | Issue 2/2013

Login to get access

Abstract

Background

Since 1998, urine screening tests have been performed on school children in Korea. We report the findings of the screening program that analyzed patients with proteinuria and/or hematuria.

Methods

Between 1999 and 2008, 5,114 children were referred to pediatric nephrologists at seven nationwide hospitals. Renal biopsies were performed on 1,478 children [28.79 % of total subjects; 26.77 % for isolated hematuria (IH), 9.09 % for isolated proteinuria (IP), and 51.19 % for combined hematuria and proteinuria (CHP)] who showed abnormal renal function, persistent hematuria and/or proteinuria for more than 6 months, nephrotic-range proteinuria, or those with underlying systemic diseases.

Results

Chronic glomerulonephritis (GN) was detected in 25 % of all visiting subjects. The most common findings in renal biopsies were immunoglobulin A (IgA) nephropathy in 38.97 %, mesangial proliferative GN in 24.29 %, and thin basement membrane nephropathy in 13.13 %. Compared with the relative frequency of renal diseases associated with urinary abnormalities, CHP (46.90 %) and nephrotic-range proteinuria (69.96 %) groups had more frequent GN than the others. Abnormal findings on renal ultrasound with or without Doppler scan were noted in 462 cases (suspected nutcracker phenomenon, 159; increased parenchymal echogenicity, 92; hydronephrosis, 75; simple cyst, 47).

Conclusion

Mass urine screening tests could detect asymptomatic GN in its early stages. Initial aggressive diagnosis and treatment for CHP and nephrotic-range groups may prove helpful as interventions that delay chronic kidney disease progression. These findings may assist in the development of diagnostic and management guidelines for relatively mild urinary abnormalities, such as IH or low-grade IP.
Literature
1.
go back to reference Cho BS, Kim SD, Choi YM, Kang HH. School urinalysis screening in Korea: prevalence of chronic renal disease. Pediatr Nephrol. 2001;16:1126–8.PubMedCrossRef Cho BS, Kim SD, Choi YM, Kang HH. School urinalysis screening in Korea: prevalence of chronic renal disease. Pediatr Nephrol. 2001;16:1126–8.PubMedCrossRef
2.
go back to reference Park YH, Choi JY, Chung HS, Koo JW, Kim SY, Namgoong MK, et al. Hematuria and proteinuria in a mass school urine screening test. Pediatr Nephrol. 2005;20:1126–30.PubMedCrossRef Park YH, Choi JY, Chung HS, Koo JW, Kim SY, Namgoong MK, et al. Hematuria and proteinuria in a mass school urine screening test. Pediatr Nephrol. 2005;20:1126–30.PubMedCrossRef
3.
go back to reference Harambat J, van Stralen KJ, Kim JJ, Tizard EJ. Epidemiology of chronic kidney disease in children. Pediatr Nephrol. 2012;27:363–73.PubMedCrossRef Harambat J, van Stralen KJ, Kim JJ, Tizard EJ. Epidemiology of chronic kidney disease in children. Pediatr Nephrol. 2012;27:363–73.PubMedCrossRef
4.
go back to reference Imai E, Yamagata K, Iseki K, Iso H, Horio M, Mkino H, et al. Kidney disease screening program in Japan: history, outcome, and perspectives. Clin J Am Soc Nephrol. 2007;2:1360–6.PubMedCrossRef Imai E, Yamagata K, Iseki K, Iso H, Horio M, Mkino H, et al. Kidney disease screening program in Japan: history, outcome, and perspectives. Clin J Am Soc Nephrol. 2007;2:1360–6.PubMedCrossRef
5.
go back to reference Research Group on Progressive Chronic Renal Disease. Nationwide and long-term survey of primary glomerulonephritis in Japan as observed in 1850 biopsied cases. Nephron 1999;82:205–13. Research Group on Progressive Chronic Renal Disease. Nationwide and long-term survey of primary glomerulonephritis in Japan as observed in 1850 biopsied cases. Nephron 1999;82:205–13.
6.
go back to reference Levy M, Berger J. Worldwide perspective of IgA nephropathy. Am J Kidney Dis. 1988;12:340–7.PubMed Levy M, Berger J. Worldwide perspective of IgA nephropathy. Am J Kidney Dis. 1988;12:340–7.PubMed
7.
go back to reference Kitagawa T. Lessons learned from the Japanese nephritis screening study. Pediatr Nephrol. 1988;2:256–63.PubMedCrossRef Kitagawa T. Lessons learned from the Japanese nephritis screening study. Pediatr Nephrol. 1988;2:256–63.PubMedCrossRef
8.
go back to reference Dimitrijevic J, Kovacevic Z, Jovanovic D, Ignjatovic L, Rabrenovic V, Djukanovic L. Asymptomatic urinary abnormalities: histopathological analysis. Pathol Res Pract. 2009;205:295–302.PubMedCrossRef Dimitrijevic J, Kovacevic Z, Jovanovic D, Ignjatovic L, Rabrenovic V, Djukanovic L. Asymptomatic urinary abnormalities: histopathological analysis. Pathol Res Pract. 2009;205:295–302.PubMedCrossRef
9.
go back to reference Shen P, He L, Li Y, Wang Y, Chan M. Natural history and prognostic factors of IgA nephropathy presented with isolated microscopic hematuria in Chinese patients. Nephron Clin Pract. 2007;106:c157–61.PubMedCrossRef Shen P, He L, Li Y, Wang Y, Chan M. Natural history and prognostic factors of IgA nephropathy presented with isolated microscopic hematuria in Chinese patients. Nephron Clin Pract. 2007;106:c157–61.PubMedCrossRef
10.
go back to reference Vivante A, Afek A, Frenkel-Nir Y, Tzur D, Farfel A, Golan E, et al. Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease. JAMA. 2011;306:729–36.PubMedCrossRef Vivante A, Afek A, Frenkel-Nir Y, Tzur D, Farfel A, Golan E, et al. Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease. JAMA. 2011;306:729–36.PubMedCrossRef
11.
go back to reference Coppo R, Gianoglio B, Porcellini MG, Maringhini S. Frequency of renal diseases and clinical indications for renal biopsy in children (report of the Italian National Registry of Renal Biopsies in Children). Group of Renal Immunopathology of the Italian Society of Pediatric Nephrology and Group of Renal Immunopathology of the Italian Society of Nephrology. Nephrol Dial Transplant. 1998;13:293–7.PubMedCrossRef Coppo R, Gianoglio B, Porcellini MG, Maringhini S. Frequency of renal diseases and clinical indications for renal biopsy in children (report of the Italian National Registry of Renal Biopsies in Children). Group of Renal Immunopathology of the Italian Society of Pediatric Nephrology and Group of Renal Immunopathology of the Italian Society of Nephrology. Nephrol Dial Transplant. 1998;13:293–7.PubMedCrossRef
12.
go back to reference Lin CY, Hsieh CC, Chen WP, Yang LY, Wang HH. The underlying diseases and follow-up in Taiwanese children screened by urinalysis. Pediatr Nephrol. 2001;16:232–7.PubMedCrossRef Lin CY, Hsieh CC, Chen WP, Yang LY, Wang HH. The underlying diseases and follow-up in Taiwanese children screened by urinalysis. Pediatr Nephrol. 2001;16:232–7.PubMedCrossRef
13.
go back to reference Yamagata K, Iseki K, Nitta K, Imai H, Iino Y, Matsuo S, et al. Chronic kidney disease perspectives in Japan and the importance of urinalysis screening. Clin Exp Nephrol. 2008;12:1–8.PubMedCrossRef Yamagata K, Iseki K, Nitta K, Imai H, Iino Y, Matsuo S, et al. Chronic kidney disease perspectives in Japan and the importance of urinalysis screening. Clin Exp Nephrol. 2008;12:1–8.PubMedCrossRef
14.
go back to reference Williams PS, Fass G, Bone JM. Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure. Q J Med. 1988;67:343–54.PubMed Williams PS, Fass G, Bone JM. Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure. Q J Med. 1988;67:343–54.PubMed
15.
go back to reference Burton C, Harris KP. The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis. 1996;27:765–75.PubMedCrossRef Burton C, Harris KP. The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis. 1996;27:765–75.PubMedCrossRef
16.
go back to reference Yoshikawa N, Kitagawa K, Ohta K, Tanaka R, Nakamura H. Asymptomatic constant isolated proteinuria in children. J Pediatr. 1991;119:375–9.PubMedCrossRef Yoshikawa N, Kitagawa K, Ohta K, Tanaka R, Nakamura H. Asymptomatic constant isolated proteinuria in children. J Pediatr. 1991;119:375–9.PubMedCrossRef
17.
go back to reference Koshy SM, Garcia–Garcia G, Pamplona JS, Renoirte-Lopez K, Perez-Cortes G, Gutierrez ML, et al. Screening for kidney disease in children on World Kidney Day in Jalisco, Mexico. Pediatr Nephrol. 2009;24:1219–25.PubMedCrossRef Koshy SM, Garcia–Garcia G, Pamplona JS, Renoirte-Lopez K, Perez-Cortes G, Gutierrez ML, et al. Screening for kidney disease in children on World Kidney Day in Jalisco, Mexico. Pediatr Nephrol. 2009;24:1219–25.PubMedCrossRef
18.
go back to reference Pugia MJ, Lott JA, Kajima J, Saambe T, Sasaki M, Kuromoto K, et al. Screening school children for albuminuria, proteinuria and occult blood with dipsticks. Clin Chem Lab Med. 1999;37:149–57.PubMedCrossRef Pugia MJ, Lott JA, Kajima J, Saambe T, Sasaki M, Kuromoto K, et al. Screening school children for albuminuria, proteinuria and occult blood with dipsticks. Clin Chem Lab Med. 1999;37:149–57.PubMedCrossRef
19.
go back to reference Yap HK, Quek CM, Shen Q, Joshi V, Chia KS. Role of urinary screening programmes in children in the prevention of chronic kidney disease. Ann Acad Med Singapore. 2005;34:3–7.PubMed Yap HK, Quek CM, Shen Q, Joshi V, Chia KS. Role of urinary screening programmes in children in the prevention of chronic kidney disease. Ann Acad Med Singapore. 2005;34:3–7.PubMed
Metadata
Title
A nationwide study of mass urine screening tests on Korean school children and implications for chronic kidney disease management
Authors
Byoung-Soo Cho
Won-Ho Hahn
Hae Il Cheong
Inseok Lim
Cheol Woo Ko
Su-Young Kim
Dae-Yeol Lee
Tae-Sun Ha
Jin-Soon Suh
Publication date
01-04-2013
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 2/2013
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-012-0672-9

Other articles of this Issue 2/2013

Clinical and Experimental Nephrology 2/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.